$GGB

Lopes Rafael Gamboa sold $264K of GGB

Lopes Rafael Gamboa sold 51,800 shares of GERDAU S.A. (GGB) at $5.09 ($0.26M total) on 2026-09-17.

Original reporting
SEC EDGAR · Lopes Rafael Gamboa
Published Sep 21, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 10:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GGB
Bearish
medium confidence
Mentioned
$GGB
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GGBBearishLow
01

Why it matters

The insider sale is a standard disclosure with modest size; traders may monitor for further insider activity.

02

Market read

Provides a fresh primary source of insider selling; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 4/10Novelty 4/10Timing: Filed Sep 21, reflecting a recent Sep 17 sale.

Background

GERDAU S.A. (ticker GGB) is a major steel producer listed on the NYSE.

Company-level read

Ticker impact

$GGBBearishMedium confidence
Context

Insider Lopes Rafael Gamboa sold 51,800 shares of GERDAU S.A. for $263,662 on Sep 17, 2026.

Expected impact

Minor downward pressure on GGB price in the short term.

Evidence & confidence

Form 4 filings are primary sources; the transaction size is modest relative to market cap, so impact is limited.

Market effects

None significant; the sale is company‑specific.

No broader regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale may be routine portfolio rebalancing, not a negative signal.

Key entities

  • Lopes Rafael Gamboa

    Reporter of the Form 4 transaction.

  • GERDAU S.A.

    Issuer of the shares sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GGBMed

Gerdau (GGB) Q3 2026 Earnings Call Transcript

Gerdau S.A. reported Q3 2026 earnings, highlighting BRL 1.7B free cash flow, BRL 0.34/share dividends, and a solid balance sheet. The company expects to return over BRL 1.85B to shareholders in 2026. North American operations showed strong demand, while Brazil faced seasonal slowdowns and import challenges. The company plans adjustments to improve Brazilian profitability and is awaiting government support on trade and energy policies.

$GGBMed

What Gerdau (GGB) Said on Its Q3 Earnings Call

Gerdau (GGB) is expanding capacity at its Texas facility, with full production expected by 2027. The company focuses on organic investments, not spin-offs or major acquisitions. Management discussed potential trade impacts on regional margins. In Brazil, Gerdau faces import pressure but plans productivity improvements. The company announced dividends and reduced capital expenditure plans to BRL 4 billion. Net debt to EBITDA is 0.58 times, with a positive outlook from S&P.

$GGBMedAI 8/10

Gerdau ADR earnings missed, revenue topped estimates

Gerdau ADR (GGB) reported Q3 EPS of $0.159, missing estimates of $0.165, while revenue of $3.75B exceeded expectations. The stock is down 4.23% over 3 months but up 37.28% year-over-year. Analysts revised EPS positively twice in the last 90 days. InvestingPro rates its financial health as good.